Millennium Management
MENS

Millennium Management’s Jyong Biotech MENS Stock Holding History

Millennium Management’s Portfolio MENS Stock Details MENS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.4K Sell
14,590
-25,668
-64% -$62.8K ﹤0.01% 5472
2025
Q4 		$159K Buy
40,258
+27,245
+209% +$962K ﹤0.01% 5533
2025
Q3 		$512K Buy
+13,013
New +$468K ﹤0.01% 5056

Other funds holding MENS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.32B AUM 51.82% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management's MENS Position: Q1 2026 in Review

Millennium Management reduced its Jyong Biotech (MENS) stake by 64% in Q1 2026, selling an estimated $62.8K and leaving 14,590 shares worth $31.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5472.

Millennium Management first reported a position in MENS in Q3 2025 and has held it in 3 quarters since. The position peaked at $512K in Q3 2025. 17 funds tracked by Wall St. Rank hold MENS as of Q1 2026.

  • Millennium Management held 14,590 shares of Jyong Biotech worth $31.4K as of Q1 2026.
  • Millennium Management sold 25,668 Jyong Biotech shares in Q1 2026, an estimated $62.8K.
  • Jyong Biotech made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5472 holding.
  • Millennium Management first reported a position in Jyong Biotech in Q3 2025 and has held it in 3 quarters since.
  • Millennium Management's Jyong Biotech position peaked at $512K in Q3 2025.
  • 17 funds tracked by Wall St. Rank held Jyong Biotech as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.